Amir Nashat

CIK 1575843 · last filed 2026-06-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$90.39M
Companies
10
Total Filings
82
Lifetime Open-Market Net
-$16.51M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

FATE price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
10835 ROAD TO THE CURE
SUITE 205
SAN DIEGO, CA 92121
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count in each company: direct shares plus every indirect holder (trusts, LLCs, partnerships, family members) on the latest Form 4 that lists them. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CAMP Director 197,661 $3.99 $788.7K $12.00M 4 2026-06-12
Morphic Holding, Inc. (MORF) Delisted Director 1,991,731 $56.99 $113.51M -$8.69M 9 2024-06-05
SRRK Director 1,689,592 $50.52 $85.36M $7.87M 13 2024-05-13
Metacrine, Inc. (MTCR) Delisted Director 178,942 $0.49 $88.6K $2.99M 3 2022-09-06
Syros Pharmaceuticals, Inc. (SYRS) Delisted Director 153,833 $0.00 $62 $5.00M 9 2022-06-02
FATE Director 11,034 $1.04 $11.5K -$17.96M 21 2019-08-02
Cartesian Therapeutics, Inc. (SELB) Delisted Director 52,156 $0.88 $46.0K -$1.92M 8 2019-06-18
LIFE Director 131,469 $32.20 $4.23M $0 6 2018-05-17
DNIB UNWIND, INC. (BIND) Delisted Director — — — $0 1 2015-06-10
Receptos, Inc. (RCPT) Delisted Director 770,089 — — -$15.80M 7 2013-12-10

Holdings By Holder

Who holds the shares on record: the insider directly, and each trust, LLC, partnership or family member reported as an indirect holder on the latest Form 4 that lists them. Holder names come from the filing's footnotes. Rows under No longer reported appeared on earlier filings but not the latest one, usually because the holder was emptied or folded into another; they are not counted in the total.
Symbol Holder Shares Share of Total Reported
CAMP PP VII
See Footnote
197,661 100.0% 2025-09-11
Total 197,661
MORF Direct 145 0.0% 2023-06-30
By Polaris Partners VII, L.P. 1,860,498 93.4% 2023-06-30
By Polaris Entrepreneurs' Fund VII, L.P. 130,153 6.5% 2023-06-30
By Polaris Management Co. VII L.L.C. 935 0.0% 2023-06-30
Total 1,991,731
SRRK Direct 38,639 2.3% 2024-05-13
PVPFF VI
See Footnote
1,650,953 97.7% 2024-05-13
Total 1,689,592
MTCR Polaris Partners VII, L.P.
See footnote
178,942 100.0% 2020-09-22
Total 178,942
SYRS Polaris Entrepreneurs' Fund VII, L.P.
See Footnote
153,833 100.0% 2016-07-07
Total 153,833
FATE PVPE V. PVM V is the general partner of PVPE V. The Reporting Person
See Footnote
11,034 100.0% 2019-08-02
Total 11,034
SELB Polaris Venture Partners V, L.P.
See Footnote
52,156 100.0% 2019-01-29
Total 52,156
LIFE Direct 898 0.7% 2015-05-14
By Polaris Venture Partners V, L.P. 125,992 95.8% 2015-05-14
By Polaris Venture Partners Entrepreneurs' Fund V, L.P. 2,456 1.9% 2015-05-14
Polaris Venture Partners Special Founders' Fund V, L.P. 1,260 1.0% 2015-05-14
By Polaris Venture Partners Founders' Fund V, L.P. 863 0.7% 2015-05-14
Total 131,469
RCPT Polaris Venture Partners VI, L.P.
See footnotes
770,089 100.0% 2013-12-10
Total 770,089
No longer reported
Polaris Venture Partners Founders? Fund VI, L.P.
See Footnote
959,694 — last 2013-11-22

Recent Filings · Page 8 of 9

82 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144, so not all of them end in a sale. Under each notice: the role the filer ticked on it, and whether a sale followed (a Form 4 sale within 30 days, or a sale listed on a later notice).
Filed Symbol Action Net Shares Net $ Link
2015-06-10 DNIB UNWIND, INC. (BIND) Delisted Grant (A) — $0 EDGAR
2015-05-18 FATE Grant (A) — $0 EDGAR
2015-05-15 FATE Grant (A) — $0 EDGAR
2015-05-14 LIFE Conv (C) +1,827,992 $0 EDGAR
2013-12-10 Receptos, Inc. (RCPT) Delisted Sell (S) −170,000 -$4.54M EDGAR
2013-11-22 Receptos, Inc. (RCPT) Delisted Sell (S) −169,315 -$4.23M EDGAR
2013-11-22 Receptos, Inc. (RCPT) Delisted Sell (S) −30,685 -$698.7K EDGAR
2013-11-19 Receptos, Inc. (RCPT) Delisted Sell (S) −169,315 -$4.23M EDGAR
2013-11-18 Receptos, Inc. (RCPT) Delisted Sell (S) −169,315 -$4.23M EDGAR
2013-10-07 FATE Mixed +2,473,186 $5.77M EDGAR
Showing 71–80 of 82
Page 8 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).